DOWNING HEALTHCARE EIS
Downing’s first impact fund, the Downing Healthcare EIS is its third specialist healthcare & life sciences EIS knowledge intensive fund, but the first with a clear impact focus.
The fund seeks to invest in ambitious, early-stage EIS companies in healthcare & life-sciences who contribute to the objectives of the United Nations’ Sustainable Development Goals, specifically SDG 3 (Good Health and Well-being).
These knowledge intensive companies seek to undertake research, development or innovation to develop new products and services that support SDG 3, creating value for investors and society that may not otherwise have occurred. As a knowledge intensive fund, it also provides accelerated income tax relief in the tax year of investment.
The managers consider the ESG characteristics of these companies throughout the investment process, and throughout the lifetime of the investment, aim to capture, monitor and review the progress of the business against relevant impact KPIs and report this to investors regularly.
• Downing targets a return of 3x+ for investors after a successful exit within a target of four to eight years from investment.
By investing in companies that directly contribute to our society’s health and wellbeing, Downing strongly believes it can achieve attractive and sustainable returns for investors.
Key features Closing date: This fund closes on 5 April 2022 Minimum investment: £15,000 Investment allocation: Downing aims to invest your money in a minimum of five companies across the healthcare & life sciences sector
For more information visit https://www.downing. co.uk/investor/offers/downing-healthcare-eis
MMC KNOWLEDGE INTENSIVE EIS FUND
MMC Ventures is the best performing EIS manager in the market, hitting its 200-300% target return in all vintages from 2012 to 2020. In addition to its standard EIS Fund, MMC is offering an EIS product which tackles the two most common pain points for EIS investors, uncertain allotment dates for tax planning and the administrative burden of claiming tax relief.
The MMC Knowledge Intensive Fund offers investors:
• Income tax relief for 2021/2022
• Carry back option to 2020/2021
• Reduced administration with one EIS5 certificate
Importantly, the MMC Knowledge Intensive EIS Fund invests in the same high-growth transformative tech companies as its top-performing MMC EIS Fund, but in a structure which simplifies tax planning.
Key Fund information:
• Min. investments: £25,000
• Close date: 1st April 2022
• Portfolio size: approx. 10 investments
• Target raise: £30 million
For more information visit mmc.vc/funds or contact the MMC team at invest@mmc.vc
O2H HUMAN HEALTH KNOWLEDGE-INTENSIVE EIS FUND
The o2h human health EIS fund is the first HMRC approved Knowledge-Intensive fund that invests in EIS qualifying knowledge intensive companies.
Fund Focus:
We fund the development of novel therapeutic treatments; helping build new services and tools offerings throughout the biotech ecosystem; and spur the creation of software & artificial intelligence that will help change the UK healthcare.
To date o2h Ventures has invested into over 35 companies, several of which have now raised significant funds from overseas, listed and built game changing drugs to benefit human health.
Deployment Timeline:
Investing into a Knowledge-intensive EIS fund offers several benefits like better predictability for your tax planning. If you invest in a KI approved EIS fund, the investment date for income tax purposes is the date the fund closes. In other words, you know at the point of investment that you should be able to use the income tax relief in the tax year in which you invest or carry back to the previous tax year – effectively getting back tax you’ve already paid.
• We have two closes per year and the next one is on 5th April 2022.
• The minimum investment is £25k.*
• Carry Back EIS Tax Relief: Carry back EIS tax relief to 2020/21, or the benefit of investing in this current year, deadline April 1st (capital at risk, depending on individual circumstances)
• Risk Management: Two part investment focus of Access & Incubation, providing unique opportunities and reducing investment risk by being deeply involved.
• Portfolio Diversification: Aiming to build a diverse portfolio for investors with an initial Portfolio of 5-10 unquoted and/or AIM-listed companies.
For more information, please visit https://o2hventures.com
Continue reading article…
